Nike's declining margins, high valuation, and rising competition signal financial challenges. Click here to read an analysis ...
Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...
MarketBeat on MSN6h
Oklo's Stock Price Meltdown Is an Opportunity to BuyCompanyOverview|NYSE:OKLO] Oklo’s (NYSE: OKLO) stock price is melting down and may head even lower before the bottom is found ...
The collapse of 23andMe is sparking important conversations — and unanswered questions — about genetic data privacy and ...
Boing Boing on MSN1d
The stoner story behind today's most recognizable record store logoMy son and I are both lifelong vinyl collectors. Living in the San Francisco Bay Area, we've always noticed that if you spot ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers across ...
Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...
The Consumer Financial Protection Bureau is meant to protect us from predatory finance. That’s why Trump wants it gone.
Plus Therapeutics shares are trading higher by 183% during Thursday's session. The company announced that the FDA accepted ...
In an unveiling this week at the 2025 ProMat show, the leading event in the manufacturing and supply chain industry, ...
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback